Clinical Trial
Accepted on 10 Mar 2025
Acceptability of the live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) among young women at high risk of HIV acquisition in South Africa: data from the Phase 2 placebo-controlled trial
in HIV and STIs